A detailed history of Victory Capital Management Inc transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 33,549 shares of PACB stock, worth $60,388. This represents 0.0% of its overall portfolio holdings.

Number of Shares
33,549
Previous 34,129 1.7%
Holding current value
$60,388
Previous $46,000 23.91%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$1.2 - $2.17 $696 - $1,258
-580 Reduced 1.7%
33,549 $57,000
Q2 2024

Aug 05, 2024

BUY
$1.36 - $3.65 $1,281 - $3,438
942 Added 2.84%
34,129 $46,000
Q1 2024

May 03, 2024

SELL
$3.52 - $9.59 $3.74 Million - $10.2 Million
-1,061,537 Reduced 96.97%
33,187 $124,000
Q4 2023

Feb 05, 2024

BUY
$5.97 - $10.36 $2.64 Million - $4.58 Million
442,250 Added 67.78%
1,094,724 $10.7 Million
Q3 2023

Nov 06, 2023

SELL
$8.23 - $13.93 $9.81 Million - $16.6 Million
-1,191,647 Reduced 64.62%
652,474 $5.45 Million
Q2 2023

Jul 27, 2023

BUY
$9.97 - $14.05 $1.92 Million - $2.7 Million
192,332 Added 11.64%
1,844,121 $24.5 Million
Q1 2023

May 02, 2023

BUY
$7.94 - $12.02 $12.9 Million - $19.6 Million
1,628,823 Added 7092.32%
1,651,789 $19.1 Million
Q4 2022

Feb 10, 2023

BUY
$5.67 - $11.2 $1,173 - $2,318
207 Added 0.91%
22,966 $187,000
Q4 2022

Feb 09, 2023

SELL
$5.67 - $11.2 $1,224 - $2,419
-216 Reduced 0.94%
22,759 $186,000
Q3 2022

Nov 02, 2022

BUY
$3.93 - $8.57 $8,532 - $18,605
2,171 Added 10.44%
22,975 $133,000
Q2 2022

Aug 01, 2022

BUY
$4.02 - $10.43 $631 - $1,637
157 Added 0.76%
20,804 $92,000
Q1 2022

May 04, 2022

SELL
$8.43 - $20.9 $90,066 - $223,295
-10,684 Reduced 34.1%
20,647 $131,000
Q4 2021

Feb 07, 2022

SELL
$19.26 - $30.08 $176,344 - $275,412
-9,156 Reduced 22.61%
31,331 $641,000
Q3 2021

Nov 02, 2021

BUY
$24.86 - $35.02 $51,186 - $72,106
2,059 Added 5.36%
40,487 $1.03 Million
Q2 2021

Aug 03, 2021

SELL
$22.3 - $36.02 $38,422 - $62,062
-1,723 Reduced 4.29%
38,428 $1.34 Million
Q1 2021

May 04, 2021

BUY
$26.38 - $51.15 $60,990 - $118,258
2,312 Added 6.11%
40,151 $1.34 Million
Q4 2020

Feb 01, 2021

BUY
$10.5 - $28.5 $120,120 - $326,040
11,440 Added 43.33%
37,839 $982,000
Q3 2020

Nov 09, 2020

BUY
$3.61 - $9.87 $8,331 - $22,779
2,308 Added 9.58%
26,399 $261,000
Q2 2020

Aug 07, 2020

SELL
$2.65 - $4.03 $1,534 - $2,333
-579 Reduced 2.35%
24,091 $83,000
Q1 2020

May 04, 2020

SELL
$2.36 - $5.26 $16,781 - $37,403
-7,111 Reduced 22.38%
24,670 $75,000
Q4 2019

Feb 06, 2020

BUY
$4.6 - $5.57 $30,189 - $36,555
6,563 Added 26.03%
31,781 $163,000
Q4 2019

Feb 04, 2020

SELL
$4.6 - $5.57 $34,610 - $41,908
-7,524 Reduced 22.98%
25,218 $118,000
Q3 2019

Nov 12, 2019

BUY
$4.99 - $6.16 $163,382 - $201,690
32,742 New
32,742 $169,000
Q4 2018

Feb 05, 2019

SELL
$3.99 - $7.82 $1.2 Million - $2.35 Million
-300,000 Closed
0 $0
Q3 2018

Nov 01, 2018

BUY
$3.52 - $5.55 $1.06 Million - $1.67 Million
300,000 New
300,000 $1.62 Million

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $405M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.